Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
+$437M |
| 2 |
AbbVie
ABBV
|
+$380M |
| 3 |
Workday
WDAY
|
+$366M |
| 4 |
Synopsys
SNPS
|
+$323M |
| 5 |
Advanced Micro Devices
AMD
|
+$286M |
Top Sells
| 1 |
Adobe
ADBE
|
+$1.71B |
| 2 |
Apple
AAPL
|
+$984M |
| 3 |
Boston Scientific
BSX
|
+$642M |
| 4 |
Microsoft
MSFT
|
+$599M |
| 5 |
Texas Instruments
TXN
|
+$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Watsco
WSO
$15.8B
| $5.91M | ﹤0.01% |
19,391
-1,703
| -8% | -$519K |
|
977
AMN Healthcare
AMN
$751M
| $5.89M | ﹤0.01% |
56,501
+46,951
| +492% | +$4.9M |
|
|
IMGN
978
DELISTED
Immunogen Inc
IMGN
| $5.89M | ﹤0.01% |
1,238,327
+814,464
| +192% | +$3.87M |
|
979
Fidelity National Financial
FNF
$16.2B
| $5.79M | ﹤0.01% |
123,286
-16,353
| -12% | -$768K |
|
980
Keurig Dr Pepper
KDP
$37.5B
| $5.76M | ﹤0.01% |
151,837
+29,228
| +24% | +$1.11M |
|
981
Northrop Grumman
NOC
$83B
| $5.73M | ﹤0.01% |
12,802
-2,668
| -17% | -$1.19M |
|
982
FTI Consulting
FCN
$5.23B
| $5.7M | ﹤0.01% |
36,279
-171
| -0.5% | -$26.9K |
|
983
Nexstar Media Group
NXST
$5.98B
| $5.64M | ﹤0.01% |
29,909
-7,869
| -21% | -$1.48M |
|
984
Stanley Black & Decker
SWK
$11.9B
| $5.64M | ﹤0.01% |
40,320
-2,077
| -5% | -$290K |
|
985
Invesco
IVZ
$9.88B
| $5.64M | ﹤0.01% |
244,381
+68,341
| +39% | +$1.58M |
|
986
CMS Energy
CMS
$21.3B
| $5.63M | ﹤0.01% |
80,450
+21,682
| +37% | +$1.52M |
|
987
Omnicom Group
OMC
$14.7B
| $5.6M | ﹤0.01% |
65,995
+15,473
| +31% | +$1.31M |
|
|
SPLK
988
DELISTED
Splunk Inc
SPLK
| $5.58M | ﹤0.01% |
37,572
-641
| -2% | -$95.3K |
|
989
American Water Works
AWK
$27B
| $5.58M | ﹤0.01% |
33,678
-13,311
| -28% | -$2.2M |
|
|
COHR
990
DELISTED
Coherent Inc
COHR
| $5.54M | ﹤0.01% |
20,252
+1,534
| +8% | +$419K |
|
991
Doximity
DOCS
$12.9B
| $5.54M | ﹤0.01% |
+106,296
| New | +$5.54M |
|
992
Dianthus Therapeutics
DNTH
$1.22B
| $5.53M | ﹤0.01% |
119,670
+110,173
| +1,160% | +$5.09M |
|
|
FRC
993
DELISTED
First Republic Bank
FRC
| $5.52M | ﹤0.01% |
34,029
-8,458
| -20% | -$1.37M |
|
994
Lithia Motors
LAD
$8.64B
| $5.49M | ﹤0.01% |
18,319
+764
| +4% | +$229K |
|
995
Pyxis Oncology
PYXS
$115M
| $5.49M | ﹤0.01% |
1,396,967
-72,124
| -5% | -$283K |
|
|
SAFM
996
DELISTED
Sanderson Farms Inc
SAFM
| $5.46M | ﹤0.01% |
29,147
+2,334
| +9% | +$437K |
|
997
Maravai LifeSciences
MRVI
$376M
| $5.46M | ﹤0.01% |
154,765
-42,997
| -22% | -$1.52M |
|
998
East-West Bancorp
EWBC
$15.1B
| $5.44M | ﹤0.01% |
68,856
+40,113
| +140% | +$3.17M |
|
999
Boston Properties
BXP
$11.7B
| $5.42M | ﹤0.01% |
42,100
+13,603
| +48% | +$1.75M |
|
1000
Invesco QQQ Trust
QQQ
$371B
| $5.4M | ﹤0.01% |
14,906
-28,281
| -65% | -$10.3M |
|